Clinical Partner designed to optimise and streamline clinical development programs through our extended global network of specialist therapeutic experts.
Interesting read: Bivacor's artificial ticker with a titanium shell, the company's maglev-powered heart device is designed to provide a long-term, life-like alternative to hard-to-get organ transplants.
https://t.co/jTpUF2a8YW
Updated atatement from the JCVI:
“Unvaccinated adults aged 30 to 39 years who are not in a clinical priority group at higher risk of severe COVID-19 disease, should be preferentially offered an alternative to the AstraZeneca COVID-19 (AZD1222) vaccine”
https://t.co/1poKrC8OWi
Looking forward to today’s diagnostics meeting and discussing the service opportunities and innovations in this rapidly evolving field.
Check the link below to register!
#Diagnostic#clinicaltrials
https://t.co/Ufp649Z4uQ
@UpsilonGlobal are currently seeking 2 x SCRAs based in the Madrid or Barcelona areas, for a small European CRO specialising in oncology and regenerative medicine. Homebased, up to €60,000. Full study ownership from start-up/submissions to close-out
#jobsearch#clinicalresearch
What links @UpsilonGlobal to @JoeBiden?
Both have ties to #Sussex in The UK.
The incoming president’s great-great-great-grandfather was born near Chichester, just a few miles from our Brighton HQ!
Ok it’s a very loose link but still pretty cool!
#InaugurationDay#Biden
Due to technical difficulties, today's update to the #COVID19 Dashboard is delayed. An update is expected by 17:00 GMT.
There have been 37,535 new cases and 599 deaths within 28 days of a positive test.
A total of 4,062,501 people have now received the 1st dose of a #vaccine.
Happy Monday all! How do we feel about Monday mornings at the moment? Are you up and active, or is the snooze button king?
#mondaythoughts#GoodMorningTwitterWorld
Great news for the over-70s as they will now be included in the COVID-19 Vaccination rollout from today. Looks like we’re currently on course to the hit the ambitious targets @GOVUK has set #covid19#vaccines https://t.co/dpJmgaAxye
@Baddiel We felt the same way, then ended up completing the entries series within a week. It’s compelling yet terrifying at the same time. Actors and actresses are phenomenal 🙌
Travel to the UK from every country in South America, as well as Portugal, has been banned due to fears over the #coronavirus variant first identified in Brazil https://t.co/k42hTTDHJm
TGIF! Starting Friday with some positivity, learning that the R-rate is as low as 0.6 in some parts of England 🙌 It’s certainly not time to get complacent, but these are signs the positive effects of lockdown 3.0 💪🏻#StayHome#StaySafe#ProtectTheNHS
Slowly but surely the vaccine rollout is ramping up with 3million vaccines being administered already. With @BorisJohnson repeatedly stating 24/7 vaccines will be available as soon as the manufacturing allows, it feels like we may be seeing some light at the end of the tunnel
What to learn more about the COVID-19 vaccines such as vaccine ingredients and safety information?
You find out more on our Vaccine Knowledge Project.
https://t.co/TAPYyroa4H
#COVID19#OxfordVaccineGroup
🔄𝗥𝗲𝘁𝘄𝗲𝗲𝘁 𝘁𝗼 𝘀𝘁𝗼𝗽 𝗺𝗶𝘀𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻🔄
Some great news regarding the @valnevaSE Covid vaccine, with the @GOVUK securing early access to 60 million doses. This is now the fifth @NIHRresearch-supported vaccine to enter clinical trials in the UK, alongside Oxford/AstraZeneca, Imperial College London, Novavax and Janssen
#Coronavirus: An 82-year-old man has become the first person in the world to receive the Oxford-AstraZeneca vaccine since it was approved for use https://t.co/s9NHXcNbTS